Abbott

Company

Investment-firm

Last deal

$100K

Amount

Post-IPO Debt

Stage

15.03.2011

Date

2

all rounds

$6.8M

Total amount

General

About Company
Abbott is a global healthcare company specializing in pharmaceuticals and medical products.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Abbott Laboratories

founded date

01.01.1944

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

Abbott develops and manufactures a wide range of healthcare products, including treatments for HIV, synthetic thyroid hormone, anticonvulsant drugs, and drugs for arthritis. They also produce medical tests and diagnostic instruments used in hospitals, laboratories, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, and heart failure. Abbott operates in over 130 countries and has a product manufacturing segment called Abbott Point-of-Care, which manufactures diagnostic products for blood analysis and provides cardiac assays to the emergency room.